OGF is a constitutively expressed native opioid that is autocrine produced and secreted, and interacts with the OGF receptor (OGFr) to inhibit the growth of pancreatic cancer cells in vitro and in tumor xenografts [2,3]. The gene discussed is PENK; the disease is neoplasm.